Pfizer Ltd (PFIZ.NS)
PFIZ.NS on National Stock Exchange of India
2,579.00INR
7:49am BST
2,579.00INR
7:49am BST
Change (% chg)
Rs14.30 (+0.56%)
Rs14.30 (+0.56%)
Prev Close
Rs2,564.70
Rs2,564.70
Open
Rs2,583.90
Rs2,583.90
Day's High
Rs2,597.95
Rs2,597.95
Day's Low
Rs2,557.85
Rs2,557.85
Volume
4,197
4,197
Avg. Vol
25,419
25,419
52-wk High
Rs2,675.00
Rs2,675.00
52-wk Low
Rs1,681.00
Rs1,681.00
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 19.45 | March | 16 Jul 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 3 | 3 | 2 | 1 |
| (3) HOLD | 1 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.00 | 2.00 | 2.00 | 2.00 |
Consensus Estimates Analysis
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 4 | 4,857.08 | 5,050.00 | 4,645.00 | -- |
| Year Ending Mar-18 | 3 | 20,058.20 | 21,051.00 | 19,441.70 | -- |
| Year Ending Mar-19 | 4 | 22,863.80 | 25,041.00 | 21,584.10 | 24,411.50 |
| Year Ending Mar-20 | 4 | 25,571.10 | 28,818.00 | 23,375.60 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 2 | 19.45 | 19.81 | 19.10 | -- |
| Year Ending Mar-18 | 3 | 74.49 | 77.60 | 70.20 | -- |
| Year Ending Mar-19 | 4 | 90.91 | 104.60 | 84.00 | 79.82 |
| Year Ending Mar-20 | 4 | 103.63 | 126.10 | 94.41 | -- |
Historical Surprises
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-18 | 4,857.08 | 5,199.50 | 342.42 | 7.05 |
| Quarter Ending Dec-17 | 4,644.00 | 4,886.20 | 242.20 | 5.22 |
| Quarter Ending Sep-17 | 4,838.00 | 5,948.20 | 1,110.20 | 22.95 |
| Quarter Ending Jun-17 | 4,603.31 | 4,209.10 | 394.21 | 8.56 |
| Quarter Ending Mar-17 | 5,043.61 | 4,380.60 | 663.01 | 13.15 |
| Earnings (per share) | ||||
| Quarter Ending Mar-18 | 19.45 | 22.84 | 3.39 | 17.40 |
| Quarter Ending Jun-17 | 13.21 | 12.50 | 0.71 | 5.37 |
| Quarter Ending Mar-17 | 15.13 | 14.87 | 0.26 | 1.72 |
| Quarter Ending Dec-16 | 20.20 | 9.47 | 10.73 | 53.12 |
| Quarter Ending Sep-16 | 18.73 | 5.00 | 13.73 | 73.30 |
Consensus Estimates Trend
Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Mar-18 | 4,857.08 | -- | -- | -- | -- |
| Year Ending Mar-18 | 20,058.20 | -- | -- | -- | -- |
| Year Ending Mar-19 | 22,863.80 | 22,863.80 | 22,863.80 | 22,717.00 | 24,411.50 |
| Year Ending Mar-20 | 25,571.10 | 25,571.10 | 25,571.10 | 26,152.30 | -- |
| Earnings (per share) | |||||
| Quarter Ending Mar-18 | 19.45 | -- | -- | -- | -- |
| Year Ending Mar-18 | 74.49 | -- | -- | -- | -- |
| Year Ending Mar-19 | 90.91 | 90.91 | 90.91 | 88.82 | 79.82 |
| Year Ending Mar-20 | 103.63 | 103.63 | 103.63 | 105.63 | -- |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Mar-20 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-18 | -- | -- | -- | -- |
| Year Ending Mar-19 | 0 | 0 | 0 | 0 |
| Year Ending Mar-20 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- BRIEF-India's Pfizer March Qtr Profit Rises
- BRIEF-Pfizer Ltd Says Pfizer Inc Has Not Yet Made Decision w.r.t Strategic Alternatives For Global Consumer Healthcare Business
- BRIEF-Pfizer Says Ravi Prakash Bhagavathula Resigned As CFO
- Lawyer Andrei Iancu confirmed to lead U.S. patent office
- BRIEF-India's Pfizer Dec-Qtr Profit Rises